Sep 16, 2020 — Accelerate Diagnostics today announced that the Company has received U.S. Food and Drug Administration (FDA) clearance for a new suite of product enhancements to the Accelerate Pheno® system to improve performance and expand the system’s antimicrobial susceptibility testing (AST) menu for bloodstream infections. The new release features improvements in susceptibility testing performance for four important […]
Sep 10, 2020 — Accelerate Diagnostics and BioCheck, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the individual BioCheck SARS-CoV-2 IgM Test Kit and the BioCheck SARS-CoV-2 IgG Test Kit. Today’s announcement follows the recent EUA approval of the fully automated MS-Fast instrument and the BioCheck SARS-CoV-2 IgM […]
Sep 03, 2020 — In an article released today, the Arizona Daily Star/Tucson.com covers the new COVID-19 testing solution offered by Accelerate Diagnostics under FDA Emergency Use Authorization. Read the full story here.
Aug 24, 2020 — Accelerate Diagnostics today announced that Nedal Safwat has been appointed its Chief Strategy Officer. Dr. Safwat has over 20 years of experience in the medical device, in vitro diagnostics, and life sciences industries. He previously served as the Executive Director of the ID/AST Franchise at bioMerieux.joins Accelerate from BioMerieux, where he served in multiple roles […]
See all news
Enter your email address below for access to photos, logos and videos.
Connect with us